Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Source: Thailand Medical News  Jan 10, 2020  3 years, 10 months, 3 weeks, 3 days, 18 hours, 45 minutes ago

Glycoinsulin : New Fibril Free Insulin Compound Developed To Improve Therapy For Diabetes Patients

Glycoinsulin : New Fibril Free Insulin Compound Developed To Improve Therapy For Diabetes Patients
Source: Thailand Medical News  Jan 10, 2020  3 years, 10 months, 3 weeks, 3 days, 18 hours, 45 minutes ago
A breakthrough discovery that could improve the clinical delivery of insulin for people living with diabetes, medical scientists from Australia have developed a non-fibrillating form of human insulin.

Utilizing a novel glycosylation technique, an international research team led by Associate Professor Dr Akhter Hossain from the Florey Institute of Neuroscience and Mental Health, has successfully synthesised an insulin analogue called glycoinsulin that demonstrates the same glucose-lowering effects as native insulin in preclinical studies without fibril formation.

Most often, fibrils can arise when insulin compounds aggregate together forming clumps. For people with diabetes who rely on pump infusions to administer insulin, fibrils pose serious risk in blocking the delivery of insulin which can potentially lead to life threatening under-dosing.

Dr Hossain said that the discovery of glycoinsulin presents a promising solution for patients.

Dr Hossain told Thailand Medical News, "Not only did our research demonstrate that glycoinsulin does not form fibrils, even at high temperature and concentration, but also that it is more stable in human serum than native insulin. Together these findings could position glycoinsulin as an excellent candidate for use in insulin pumps and a way to improve the shelf life of insulin products. We now hope to streamline the manufacturing process for glycoinsulin so this compound can be further investigated in larger, clinical studies."

More than 25,000 people in Australia and 350,000 people in the United States use insulin pumps as part of their diabetes management.

Insulin pump infusion sets are required to be replaced every 24 hours to 72 hours to mitigate the occurrence of fibrils, in what can cause significant patient burden and medicine wastage.  In the USA alone, more than US$1 billion could be saved per year if the usage period for insulin increased from two to six days.

Significant to the success of the study was the engineering of an insulin-sugar complex from egg yolks using a method jointly developed by collaborators, Associate Professor Ryo Okamoto and Professor Yasuhiro Kajihara, from Osaka University, Japan.

Dr John Wade, a Professor from the Florey Institute of Neuroscience and Mental Health who co-led the research commented to Th ailand Medical News on the landmark success of the research, "Typically, the chemical modification of insulin causes structural destabilisation and inactivation, but we were able to successfully synthesise glycoinsulin in a way that retains its insulin-like helical structure. The result is an almost fully active insulin analogue which has demonstrated near-native binding to insulin receptors in both lab and animal studies."

Professor Greg Johnson, CEO of Diabetes Australia welcomed the research findings saying they had the potential to make life easier for people living with diabetes who use insulin pumps.

Professor Johnson commented, "It is nearly 100 years since the discovery of insulin and it's very exciting that we see new discoveries for insulin, and insulin-like molecules, that have the potential to ease the day to day burden and cost for people with diabetes.”
Reference : Mohammed Akhter Hossain et al, Total Chemical Synthesis of a Nonfibrillating Human Glycoinsulin, Journal of the American Chemical Society (2019). DOI: 10.1021/jacs.9b11424


Jun 10, 2023  6 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news